Limited impact of passive non-neutralizing antibody immunization in acute SIV infection on viremia control in rhesus macaques.

Abstract

BACKGROUND:

Antiviral antibodies, especially those with neutralizing activity against the incoming strain, are potentially important immunological effectors to control human immunodeficiency virus (HIV) infection. While neutralizing activity appears to be central in sterile protection against HIV infection, the entity of inhibitory mechanisms via HIV and simian immunodeficiency virus (SIV)-specific antibodies remains elusive. The recent HIV vaccine trial RV144 and studies in nonhuman primate models have indicated controversial protective efficacy of HIV/SIV-specific non-neutralizing binding antibodies (non-NAbs). While reports on HIV-specific non-NAbs have demonstrated virus inhibitory activity in vitro, whether non-NAbs could also alter the pathogenic course of established SIV replication in vivo, likewise via neutralizing antibody (NAb) administration, has been unclear. Here, we performed post-infection passive immunization of SIV-infected rhesus macaques with polyclonal SIV-specific, antibody-dependent cell-mediated viral inhibition (ADCVI)-competent non-NAbs.

METHODS AND FINDINGS:

Ten lots of polyclonal immunoglobulin G (IgG) were prepared from plasma of ten chronically SIVmac239-infected, NAb-negative rhesus macaques, respectively. Their binding capacity to whole SIVmac239 virions showed a propensity similar to ADCVI activity. A cocktail of three non-NAb lots showing high virion-binding capacity and ADCVI activity was administered to rhesus macaques at day 7 post-SIVmac239 challenge. This resulted in an infection course comparable with control animals, with no significant difference in set point plasma viral loads or immune parameters.

CONCLUSIONS:

Despite virus-specific suppressive activity of the non-NAbs having been observed in vitro, their passive immunization post-infection did not result in SIV control in vivo. Virion binding and ADCVI activity with lack of virus neutralizing activity were indicated to be insufficient for antibody-triggered non-sterile SIV control. More diverse effector functions or sophisticated localization may be required for non-NAbs to impact HIV/SIV replication in vivo.

• Authors: Taku Nakane, Takushi Nomura, Shoi Shi, Midori Nakamura, Taeko K Naruse, Akinori Kimura, Tetsuro Matano, Hiroyuki Yamamoto
• Journal: PloS one (PLoS One) Vol. 8 Issue 9 Pg. e73453 ( 2013) ISSN: 1932-6203 [Electronic] United States
• PMID: 24039947 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Antibodies, Neutralizing
• Antibodies, Viral
• SAIDS Vaccines

Topics

• Animals
• Antibodies, Neutralizing
• Antibodies, Viral (immunology, therapeutic use)
• Humans
• Immunization, Passive
• Macaca mulatta (immunology, virology)
• SAIDS Vaccines (immunology, therapeutic use)
• Simian Acquired Immunodeficiency Syndrome (immunology, prevention & control, virology)
• Simian Immunodeficiency Virus (immunology)